PRADAXA

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug PRADAXA contains one active pharmaceutical ingredient (API):

1 Dabigatran
UNII SC7NUW5IIT - DABIGATRAN ETEXILATE MESYLATE

Dabigatran etexilate is a small molecule prodrug which does not exhibit any pharmacological activity. After oral administration, dabigatran etexilate is rapidly absorbed and converted to dabigatran by esterase-catalysed hydrolysis in plasma and in the liver. Dabigatran is a potent, competitive, reversible direct thrombin inhibitor and is the main active principle in plasma.

Read about Dabigatran

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
PRADAXA 110mg Hard capsule European Medicines Agency (EU) MPI, EU: SmPC
PRADAXA Coated granules European Medicines Agency (EU) MPI, EU: SmPC
PRADAXA 150mg Hard capsule European Medicines Agency (EU) MPI, EU: SmPC
PRADAXA 75mg Hard capsule European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
B01AE07 Dabigatran etexilate B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AE Direct thrombin inhibitors
Discover more medicines within B01AE07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 2753X, 2769R, 9318K, 9319L, 9320M, 9321N, 9322P, 9323Q
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 504505101119316, 504505102115314, 504505103111312, 504505104118310, 504505105114319, 504505106110317, 504505107117315, 504505108113313
Country: CA Health Products and Food Branch Identifier(s): 02312433, 02312441, 02358808
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 28863-05-09, 28864-05-09, 30190-05-12
Country: EE Ravimiamet Identifier(s): 1343359, 1343360, 1343371, 1343382, 1343393, 1343405, 1538726, 1538737, 1538748, 1538759, 1538760, 1587258, 1587269
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 08442002, 08442003, 08442005, 08442006, 08442007, 08442011
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 115330, 115341, 115364, 442705
Country: FR Base de données publique des médicaments Identifier(s): 63484283, 65570603, 65693901
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 135048, 135051, 135055, 135056, 194659, 368206, 368212, 375293, 375296
Country: HK Department of Health Drug Office Identifier(s): 57315, 57316, 60516
Country: IE Health Products Regulatory Authority Identifier(s): 36882, 36883, 60602, 60603, 60612, 60615, 60616, 60617, 60628, 60633, 60634, 60659, 60681, 60684, 60685
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 6317, 6318, 6319, 6320, 6321, 6685
Country: IT Agenzia del Farmaco Identifier(s): 038451011, 038451023, 038451035, 038451047, 038451062, 038451074, 038451086, 038451098, 038451100, 038451112, 038451124, 038451136, 038451148, 038451201, 038451213, 038451225, 038451237, 038451249, 038451252, 038451264
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1031768, 1031769, 1031770, 1031771, 1031772, 1031773, 1031774, 1031775, 1061808, 1061809, 1061810, 1061811, 1061812, 1061815, 1067398, 1067399, 1067400, 1067401, 1067402, 1091757, 1091758, 1091759, 1091760, 1091761, 1091762, 1091763
Country: NL Z-Index G-Standaard, PRK Identifier(s): 86983, 86991, 98361
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 13118, 13119, 14318
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100191706, 100191712, 100250679, 100455414, 100455421, 100455446, 100455453, 100455460, 100455478, 100455485
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W52942001, W52942002, W52942003, W52942004, W52943001, W52943002, W52943003, W52943004, W52943005, W57151001, W57151002, W57151003, W57151004, W57151005, W69037001, W69038001, W69039001, W69040001, W69041001, W69042001, W69043001
Country: SG Health Sciences Authority Identifier(s): 13697P, 13698P, 13941P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 11533041, 11533042, 11533043
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699693150042, 8699693150059, 8699693150097, 8699693150103, 8699693150127
Country: US FDA, National Drug Code Identifier(s): 0597-0108, 0597-0355, 0597-0360, 50090-3617, 50090-4480, 63629-8242
Country: ZA Health Products Regulatory Authority Identifier(s): 42/8.2/0130, 42/8.2/0131, 45/8.2/0162

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.